Newsroom-Katalog
Zeit | Boehringer Ingelheim: Meldungen vom 31.08.2008 |
---|---|
12:08 | First Landmark ARB Trial Against Placebo Shows MICARDIS(R) (Telmisartan) Reduces the Risk of Cardiovascular Death, Heart Attack and Stroke in ACE-Intolerant High-Risk Patients(1) |